Priya Mande has over 25 years of experience in the pharmaceutical and biotech sector, 12 of which were at Glaxo Wellcome and GlaxoSmithKline where she most recently supported the R&D Executive.
She has held roles across research, development, finance and business strategy & operations. She was previously at PowderMed responsible for delivery of the vaccine immunotherapeutic portfolio. Priya was the Vaccine Research Project Leader for Influenza at Pfizer before becoming Chief Operating Officer of Hybrid BioSystems in 2009 which then formed PsiOxus Therapeutics in 2010. She joined the PsiOxus Board of Directors in 2016.
Over 9 years she has overseen the growth of PsiOxus in the UK and USA and held responsibility for various parts of the business including project management, clinical development, regulatory, quality, legal, operations, HR, finance and company secretary. Priya studied Applied Biochemistry at Brunel University London, has a Diploma in Company Direction from the Institute of Directors and received her MBA with distinction from the London Business School.